General assessment of the patient with cancer for the interventional oncologist

Journal of Vascular and Interventional Radiology

Volumn 17, Issue 5, 2006, Pages 753-758

  Tuite, Catherine M ^a   Sun, Weijing ^a   Soulen, Michael C ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CA 125 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CHORIONIC GONADOTROPIN; CHROMOGRANIN A; TUMOR MARKER;

ANAMNESIS; CANCER DIAGNOSIS; CANCER PATIENT; CLINICAL ASSESSMENT; HUMAN; LABORATORY TEST; LIVER CELL CARCINOMA; MEDICAL RECORD; PATIENT ASSESSMENT; PATIENT CARE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RADIOLOGIST; REVIEW; TREATMENT PLANNING; INTERVENTIONAL RADIOLOGY; METHODOLOGY; ONCOLOGY; PATIENT PARTICIPATION;

HUMANS; MEDICAL HISTORY TAKING; MEDICAL ONCOLOGY; PATIENT CARE TEAM; PATIENT PARTICIPATION; PHYSICAL EXAMINATION; RADIOLOGY, INTERVENTIONAL; TUMOR MARKERS, BIOLOGICAL;

EID: 33745024743     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000209347.06761.DC     Document Type: Review

References (14)

1. Lefrak EA, Pitha J, Rosenbaum S, et al. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 1973; 32:302-314.
2. Maddrey WC. Drug-induced hepatotoxicity 2005. J Clin Gastroenterol 2005; 39(suppl 2):83-89.
3. Bolondi L, Masi L, Pini P. Epidemiology and clinical features of hepatocellular carcinoma. In: Bartolozzi C, Lencioni L, eds. Liver malignancies: diagnostic and interventional radiology. 1st ed. Berlin: Springer-Verlag, 1999; 42-45.
4. Chen CCH, Kenefick AL, Tang ST, et al. Utilization of comprehensive geriatric assessment in cancer patients. Crit Rev Oncol Hematol 2004; 29:53-67.
5. McFarland LV, Mulligan ME, Kwok RYY, et al. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989; 320:204-210.
6. Extermann M, Aapro M. Assessment of the older cancer patient. Hematol Oncol Clin North Am 2000; 14:63-77.
7. Kim W, Clark TWI, Baum RA, et al. Risk factors for liver abscess formation following hepatic chemoembolization. J Vasc Interv Radiol 2001; 12:965-968.
8. Harrison SA, Bacon BR. Relation of hemochromatosis with hepatocellular carcinoma: epidemiology, natural history, pathophysiology, screening, treatment, and prevention. Med Clin North Am 2005; 89:391-409.
9. Garman KS, Cohen HJ. Functional status and the elderly cancer patient. Crit Rev Oncol Hematol 2002; 43:191-208.
10. Introduction and approach to oncology. In: Pillot G, Chantler ML, Magiera HM, et al, eds. The Washington manual hematology and oncology subspecialty consult. 1st ed. Philadelphia: Lippincott Williams & Wilkins, 2003; 17-33.
11. Bucheri G, Ferrigno D, Tamburini M. Karnofsky and ECOG performance status scoring in lung cancer: a prospective longitudinal study of 536 patients from a single institution. Eur J Cancer 1996; 32A:1135-1141.
12. Lamont EB, Christakis NA. Prognostication in advanced disease. In: Berger AM, Portenoy RK, Weissman DE, eds. Principles and practice of palliative care and supportive oncology. 2d ed. Philadelphia: Lippincott Williams & Wilkins, 2002; 609-612.
13. Di Bisceglie AM. Epidemiology and clinical presentation of hepatocellular carcinoma. J Vasc Interv Radiol 2002; 13(suppl):S169-S171.
14. Charnsangavej C. Chemoembolization of liver tumors. Sem Invest Radiol 1993; 10:150-160.